Skip to main content
. Author manuscript; available in PMC: 2015 Feb 12.
Published in final edited form as: Lancet. 2012 Feb 14;379(9819):895–904. doi: 10.1016/S0140-6736(12)60195-0

Figure 3. Representative MRI and changes in scar size.

Figure 3

Short-axis MRI of heart at baseline (82 days after myocardial infarction; A) and 6 months after CDC infusion (B) in a participant randomly allocated to receive CDCs. Short-axis MRI of heart at baseline (77 days after myocardial infarction; C) and after 6 months (D) in a control. Infarct scar tissue (green arrows) is evident by areas of hyperintensity (white) whereas viable myocardium appears dark. Difference in scar size from baseline to 6 months (E) or 12 months (F). CDC=cardiosphere-derived cell.